USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
The current stock price of HLN is 10.46 USD. In the past month the price increased by 3.46%. In the past year, price increased by 11.4%.
ChartMill assigns a technical rating of 8 / 10 to HLN. When comparing the yearly performance of all stocks, HLN is one of the better performing stocks in the market, outperforming 74.18% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to HLN. HLN has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months HLN reported a non-GAAP Earnings per Share(EPS) of 0.5. The EPS increased by 6.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.84% | ||
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| Debt/Equity | 0.53 |
24 analysts have analysed HLN and the average price target is 11.78 USD. This implies a price increase of 12.62% is expected in the next year compared to the current price of 10.46.
For the next year, analysts expect an EPS growth of 5.74% and a revenue growth -1.32% for HLN
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
HALEON PLC-ADR
Building 5, First Floor, The Heights
Weybridge SURREY GB
Employees: 24000
Phone: 441932822000
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
The current stock price of HLN is 10.46 USD. The price increased by 1.26% in the last trading session.
HALEON PLC-ADR (HLN) has a dividend yield of 1.8%. The yearly dividend amount is currently 0.17.
HLN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
HLN stock is listed on the New York Stock Exchange exchange.
The Revenue of HALEON PLC-ADR (HLN) is expected to decline by -1.32% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
The outstanding short interest for HALEON PLC-ADR (HLN) is 0.42% of its float.